Treatment of non-communicable inflammatory diseases

摘要

Use of a transcription of the CEBPB gene and / or the function of the CEBPB protein inhibiting substance for the treatment of a disease selected from a group of diseases consisting of inflammatory diseases, infectious diseases and autoimmune diseases, each with an immigration of neutrophils and / or a pathogenic reaction of epithelial cells or connective tissue cells and / or a pathogenic proliferation of epithelial cells or acanthosis.